Interestingly, a study assessing the catalytic dependent and independent requirements for Tet2 found that mice with catalytically inactive mutant mice developed myeloid malignancies reminiscent of MDS (Ito et al., 2019a). The gene discussed is TET2; the disease is myeloid neoplasm.